Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
Blackmores' dedication to delivering high-quality health supplements to a wider consumer base, including the Muslim community ...
MediPharm Labs Corp. ("MediPharm", "MediPharm Labs" or the "Company") has terminated the previously announced sale of its facility in Napanee, Ontario (the "Napanee Facility") to Kensana Health Inc. ( ...
Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...
Oncotelic Therapeutics, a leader in RNA-based therapeutics, is pleased to announce that Vuong Trieu, Ph.D., Chairman & CEO, will be delivering a featured presentation at the SWCR 2025 Conference on ...
Amidst the vibrant economic landscape of Vietnam, the filling equipment market stands as a pivotal player in facilitating the efficiency and growth of various industries. With its robust manufacturing ...
Applied DNA Sciences Inc (NASDAQ:APDN) reported its financial results for the first quarter of fiscal year 2025, showcasing a notable increase in revenue but also highlighting ongoing challenges with ...
Q4 2024 Results Conference Call February 13, 2025 11:00 AM ETCompany ParticipantsDan Cuthbertson - Director, IRDean Setoguchi ...
Central University Hospital announced on the 10th that it has introduced a state-of-the-art linear accelerator that can ...
Announces Exit of DNA Tagging and Security Products and Services Business Segment - - Workforce Reduction of 20% of Headcount Implemented in January - - GMP S ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DOJoPAWP.js ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results